Weekly Digest – July 2026 Weekly Digest – July 2026 29 July 2026: ImmunityBio receives UAE Marketing Authorization for ANKTIVA in BCG-unresponsive NMIBC (CIS and papillary disease) and mNSCLC ImmunityBio announced that the United Arab Emirates has granted marketing authorization […]
Weekly Digest – July 2026 Weekly Digest – July 2026 17 July 2026: Biokin Pharma announces approval of Iza-bren in China for the treatment of recurrent/metastatic ESCC Biokin Pharma announced that China’s NMPA has approved Iza-bren for the treatment of […]
Weekly Digest – July 2026 Weekly Digest – July 2026 10 July 2026: U.S. FDA approves PADCEV plus Keytruda as neoadjuvant and adjuvant treatment for MIBC regardless of cisplatin eligibility The U.S. FDA has approved PADCEV plus KEYTRUDA as neoadjuvant […]
